Gene · 2273
Papers1,852
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
381 to 400 of 1,852
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| A novel prognostic model for papillary thyroid cancer based on epithelial-mesenchymal transition-related genes. | Cancer Med | 2022 | 35608185 | PubTator, text mining | PubMed |
| Three novel FHL1 variants cause a mild phenotype of Emery-Dreifuss muscular dystrophy. | Hum Mutat | 2022 | 35607917 | PubTator, text mining | PubMed |
| Screening for Anti-HMGCR Antibodies in a Large Single Myositis Center Reveals Infrequent Exposure to Statins and Diversiform Presentation of the Disease. | Front Immunol | 2022 | 35603214 | PubTator, text mining | PubMed |
| Clinical Importance of aCGH in Genetic Counselling of Children with Psychomotor Retardation. | Appl Clin Genet | 2022 | 35603035 | PubTator, text mining | PubMed |
| Diagnostic yield of genetic testing in heart transplant recipients with prior cardiomyopathy. | J Heart Lung Transplant | 2022 | 35581137 | PubTator, text mining | PubMed |
| Description of a novel variant in the FHL1 gene associated with hypertrophic cardiomyopathy with early and aggressive presentation. | Rev Esp Cardiol (Engl Ed) | 2022 | 35577730 | PubTator, text mining | PubMed |
| Ehrlichia SLiM ligand mimetic activates Hedgehog signaling to engage a BCL-2 anti-apoptotic cellular program. | PLoS Pathog | 2022 | 35576232 | PubTator, text mining | PubMed |
| Dynamics of the Tumor Immune Microenvironment during Neoadjuvant Chemotherapy of High-Grade Serous Ovarian Cancer. | Cancers (Basel) | 2022 | 35565437 | PubTator, text mining | PubMed |
| Cullin 3 Exon 9 Deletion in Familial Hyperkalemic Hypertension Impairs Cullin3-Ring-E3 Ligase (CRL3) Dynamic Regulation and Cycling. | Int J Mol Sci | 2022 | 35563538 | PubTator, text mining | PubMed |
| Transcriptomic Profiling of Peripheral Edge of Lesions to Elucidate the Pathogenesis of Psoriasis Vulgaris. | Int J Mol Sci | 2022 | 35563374 | PubTator, text mining | PubMed |
| Identification of Potential Muscle Biomarkers in McArdle Disease: Insights from Muscle Proteome Analysis. | Int J Mol Sci | 2022 | 35563042 | PubTator, text mining | PubMed |
| Mast cell infiltration of the choroid and protease release are early events in age-related macular degeneration associated with genetic risk at both chromosomes 1q32 and 10q26. | Proc Natl Acad Sci U S A | 2022 | 35561216 | PubTator, text mining | PubMed |
| Defects in the Proteome and Metabolome in Human Hypertrophic Cardiomyopathy. | Circ Heart Fail | 2022 | 35543134 | PubTator, text mining | PubMed |
| HIVEP3 cooperates with ferroptosis gene signatures to confer adverse prognosis in acute myeloid leukemia. | Cancer Med | 2022 | 35535739 | PubTator, text mining | PubMed |
| Identification of an elusive spliceogenic MYBPC3 variant in an otherwise genotype-negative hypertrophic cardiomyopathy pedigree. | Sci Rep | 2022 | 35508642 | PubTator, text mining | PubMed |
| α-Phenylalanyl tRNA synthetase competes with Notch signaling through its N-terminal domain. | PLoS Genet | 2022 | 35486661 | PubTator, text mining | PubMed |
| In silico identification of novel biomarkers for key players in transition from normal colon tissue to adenomatous polyps. | PLoS One | 2022 | 35486660 | PubTator, text mining | PubMed |
| Molecular studies in familial dilated cardiomyopathy - A pilot study. | Int J Cardiol Heart Vasc | 2022 | 35463915 | PubTator, text mining | PubMed |
| Anti-FHL1 antibody: welcome to a novel autoantibody in myositis. | Rheumatology (Oxford) | 2022 | 35460231 | PubTator, text mining | PubMed |
| Clinical Profile, Arrhythmias, and Adverse Cardiac Outcomes in Emery-Dreifuss Muscular Dystrophies: A Systematic Review of the Literature. | Biology (Basel) | 2022 | 35453731 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/2273/papers?page=20